Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

OPKO HEALTH, INC.

(OPK)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/15/2021 09/16/2021 09/17/2021 09/20/2021 09/21/2021 Date
3.74(c) 3.82(c) 3.94(c) 3.79(c) 3.82 Last
5 445 652 2 591 830 9 740 750 3 747 208 1 020 029 Volume
+7.47% +2.14% +3.14% -3.81% +0.79% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 1 595 M - -
Net income 2021 7,77 M - -
Net Debt 2021 - - -
P/E ratio 2021 316x
Yield 2021 -
Sales 2022 1 183 M - -
Net income 2022 -51,6 M - -
Net Debt 2022 - - -
P/E ratio 2022 -51,2x
Yield 2022 -
Capitalization 2 582 M 2 582 M -
Capi. / Sales 2021 1,62x
Capi. / Sales 2022 2,18x
Nbr of Employees 5 269
Free-Float 59,5%
More Financials
Company
OPKO Health, Inc. is a healthcare company. Its segments include Pharmaceutical, Diagnostics and Corporate. Pharmaceutical consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Diagnostics consists of the clinical laboratory operations in Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations. Through... 
Sector
Pharmaceuticals
Calendar
11/10Earnings Release
More about the company
Ratings of OPKO Health, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D+
More Ratings
All news about OPKO HEALTH, INC.
09/14OPKO HEALTH : LeaderMed Form Joint Venture to Commercialize Two Drugs in Asia
MT
09/14OPKO HEALTH : LeaderMed Group and OPKO Health Form Joint Venture to Develop and Commercial..
AQ
09/14Leadermed Group and OPKO Health Form Joint Venture to Develop and Commercialize Oxyntom..
CI
09/13OPKO HEALTH : Another Diversity Suit Stifled
AQ
09/03OPKO HEALTH, INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
08/30OPKO HEALTH : Completes Phase 2 COVID-19 Study Enrollment at 171 Subjects
MT
08/30OPKO Health Completes Enrollment in Phase 2 Trial Evaluating RAYALDEE as a Treatment fo..
GL
08/30OPKO Health, Inc. Completes Enrollment in Phase 2 Trial Evaluating Rayaldee as Treatmen..
CI
08/30OPKO Health to Participate in Two Upcoming Investment Conferences
GL
08/26RITE AID : Opko Health Unit Offer Free 'Back to School' COVID-19 Tests for New York State ..
MT
08/26Rite Aid, in Partnership with the U.S. Department of Health and Human Services, Togethe..
CI
08/16OPKO HEALTH : Unit Buys Roche's US Ariosa Prenatal Testing Business for Undisclosed Value
MT
08/16OPKO HEALTH : BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenat..
PR
08/16INSIDER TRENDS : Insider Buying Added to with Purchase of OPKO Health Shares
MT
07/30SECTOR UPDATE : Health Care Stocks Scratching Out Small Advance Just Ahead of Friday Close
MT
More news
News in other languages on OPKO HEALTH, INC.
08/30Opko Health achève le recrutement de 171 sujets pour l'étude de phase 2 COVID-19
More news
Analyst Recommendations on OPKO HEALTH, INC.
More recommendations
Chart OPKO HEALTH, INC.
Duration : Period :
OPKO Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OPKO HEALTH, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 3,79 $
Average target price 6,60 $
Spread / Average Target 74,1%
EPS Revisions
Managers and Directors
Phillip Frost Chairman & Chief Executive Officer
Jon Roger Cohen Director & Senior Vice President
Adam E. Logal CFO, Treasurer, Chief Accounting Officer & SVP
Jane H. Hsaio Vice Chairman & Chief Technical Officer
Steven D. Rubin Director & Executive Vice President-Administration
Sector and Competitors
1st jan.Capi. (M$)
OPKO HEALTH, INC.-4.05%2 582
JOHNSON & JOHNSON4.09%431 227
ROCHE HOLDING AG10.52%321 941
PFIZER, INC.19.23%247 816
NOVO NORDISK A/S48.69%229 255
ELI LILLY AND COMPANY37.20%210 000